Clinical Trials Logo

Clinical Trial Summary

To assess the surgical and economic effectiveness of the Aquamantys System in managing intra- and post-operative blood loss, and reducing transfusion needs in patients undergoing both aseptic and septic revision total knee arthroplasty.


Clinical Trial Description

The use of the saline-coupled bipolar sealing technology (Aquamantys® System, Medtronic Advanced Energy, LLC, Portsmouth, NH, USA) represents a modern approach to reducing perioperative blood loss in patients undergoing total joint arthroplasty. Unlike standard electrocautery, which use monopolar radiofrequency energy, this technology uses bipolar radiofrequency energy combined with a continuous-flow saline at the electrode tip to prevent tissue temperatures from exceeding 100 °C thus minimizing tissue charring. This eliminates the smoke and eschar formation seen with standard electrocautery. The temperature achieved is sufficient to induce a process called Transcollation(TM) which shrinks the collagen fibers in the walls of blood vessels, effectively sealing the blood vessels up to 1mm in diameter, resulting in the reduction of bleeding from soft tissue.

Suction is used to remove the saline from the surgical field with the treated tissue turning a light tan color. With normal use, the depth of penetration of this effect is typically less than 2mm. The technology is cleared by the US FDA (510(k)) and EU (CE Mark) for use on soft tissue & bone and will be used according to its intended packaging indications for use. The current assessment proposes a technique in which a disposable Aquamantys® hand piece is used to treat targeted areas which are bleeding or expected to bleed during surgery.

This postmarket study will assess the surgical and economic effectiveness of Aquamantys® System in managing intra-operative blood loss and transfusion rates in patients undergoing septic and aseptic revision TKA. ;


Study Design


Related Conditions & MeSH terms

  • Aseptic Loosening of Prosthetic Joint
  • Infection of Total Knee Joint Prosthesis

NCT number NCT02266407
Study type Interventional
Source Medtronic Surgical Technologies
Contact
Status Completed
Phase N/A
Start date June 2012
Completion date September 2012

See also
  Status Clinical Trial Phase
Recruiting NCT02594930 - Comparison of Two Different Techniques of Synovial Biopsy and Resistances of Cutaneous Smears in Suspected PPI N/A
Completed NCT02019511 - Safety Study of High-dose Methylprednisolone in Fast-track Total Knee Arthroplasty
Not yet recruiting NCT04993027 - Topical Vancomycin for Infection Prophylaxis in TJA Phase 2
Recruiting NCT05369104 - Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. Phase 2
Completed NCT03192124 - Evaluating Bactisure Wound Lavage in Orthopedic Wounds